急性心律失常的诊断和处理护理学会—培训课件.ppt

心律失常诱发因素的正确处理比使用抗心律失常药物更重要。 抗心律失常药物本身具有致心律失常作用，临床应用时应权衡利弊。 起搏装置和射频消融治疗技术的发展已成为心律失常治疗最重要的手段。 * Although the highest risk factor for SCA is a previous cardiac arrest, survival rates are extremely low. It is critical to identify other risk factors so that high-risk patients can be referred for treatment. * Although the highest risk factor for SCA is a previous cardiac arrest, survival rates are extremely low. It is critical to identify other risk factors so that high-risk patients can be referred for treatment. * Studies for heart failure patients are in progress, including the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT), the goal of which is to identify therapy that will significantly reduce death rates in patients with CHF. * Studies for heart failure patients are in progress, including the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT), the goal of which is to identify therapy that will significantly reduce death rates in patients with CHF. * The magnitude of hypertrophy1, early onset, a strong family history, and worsening symptoms appear to indicate a higher risk for SCA. 1 Spiroto P. New Engl J Med. 2000;342;1778-1785. * Another family member with LQTS may be identified in as many as 39% of patients. Specific gene markers are available for linkage analysis. * The chance of a successful resuscitation declines by about 7–10% each minute. The actual relationship between defibrillation success and time is a non-linear one, with the best chance for success probably occurring in the first 3–4 minutes. * Today’s devices are implanted pectorally, either subcutaneously or submuscularly in most patients. About 80% of the total implants in 1999 occurred in the U.S. Today’s devices are implanted pectorally, either subcutaneously or submuscularly in most patients. * Today’s devices are implanted pectorally, either subcutaneously or submuscularly in most patients. About 80% of the total implants in 1999 occurred in the U.S. Today’s devices are implant